Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Dec;97(6):1081-5.
doi: 10.1111/1523-1747.ep12492612.

Low catalase levels in the epidermis of patients with vitiligo

Affiliations
Free article

Low catalase levels in the epidermis of patients with vitiligo

K U Schallreuter et al. J Invest Dermatol. 1991 Dec.
Free article

Abstract

Suction blister roofs taken from the involved and uninvolved epidermis of patients with vitiligo showed a consistent reduction in levels of catalase compared to normal healthy controls of matched photo-skin types (Fitzpatrick classification). A decrease in catalase activity is expected to increase the concentration of hydrogen peroxide in the epidermis of these patients. Hydrogen peroxide functions as a reversible inhibitor of human tyrosinase with a KI of 8 X 10(-6) M. Also, hydrogen peroxide undergoes photochemical reduction yielding highly reactive hydroxyl radicals (OH.) and hydroxyl ions (OH-) mainly by the Haber-Weiss reaction. Hydroxyl radicals are capable of bleaching constitutional melanin and cause membrane lysis through lipid peroxidation reactions. Hydroxyl ions increase the pH in the epidermis, and as a consequence glutathione reductase activity is increased in patients with vitiligo compared to controls. Based on these new results, together with the previously reported calcium transport defect, a new hypothesis has been formulated for the pathogenesis of vitiligo.

PubMed Disclaimer

Comment in

  • Keratinocytes in vitiligo.
    Moellmann G. Moellmann G. J Invest Dermatol. 1992 Nov;99(5):665. doi: 10.1111/1523-1747.ep12668171. J Invest Dermatol. 1992. PMID: 1431235 No abstract available.

Publication types